title: American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.
authors: Barry J
authors: BJ
authors: Maron
authors: William J
authors: WJ
authors: McKenna
authors: Gordon K
authors: GK
authors: Danielson
authors: Lukas J
authors: LJ
authors: Kappenberger
authors: Horst J
authors: HJ
authors: Kuhn
authors: Christine E
authors: CE
authors: Seidman
authors: Pravin M
authors: PM
authors: Shah
authors: William H
authors: WH
authors: Spencer
authors: Paolo
authors: P
authors: Spirito
authors: Folkert J
authors: FJ
authors: Ten Cate
authors: E Douglas
authors: ED
authors: Wigle
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology; D001281:Atrial Fibrillation / Q000209:etiology / Q000628:therapy; D002304:Cardiac Pacing, Artificial; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D017115:Catheter Ablation; D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000627:therapeutic use; D015316:Genetic Therapy; D006346:Heart Septum / Q000601:surgery; D006801:Humans; D018570:Risk Assessment; D014694:Ventricular Outflow Obstruction / Q000209:etiology / Q000503:physiopathology; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000431:Ethanol; D014700:Verapamil